FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval – CNBC

Business News

  1. FDA advisors recommend Eli Lilly’s Alzheimer’s drug donanemab, paving way for approval  CNBC
  2. Eli Lilly’s donanemab, an Alzheimer’s drug, gets FDA endorsement  USA TODAY
  3. Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug  The New York Times
  4. Opinion | An Alzheimer’s Advance, Not a Cure-All  The Wall Street Journal
  5. FDA panel votes unanimously for Eli Lilly’s Alzheimer’s treatment  Yahoo Finance

Source: Business News

/by